menopause.Researchers have yet to directly test the possible effect of drug treatments for osteoporosis on a person’s risk of developing COVID-19.
Influential health organizations, such as the American College of Rheumatology, recommend that people continue taking their medications as usual.Now, researchers led by a team from the Hospital del Mar Medical Research Institute, in Barcelona, Spain, have analyzed data from 2,102 patients who received treatments for osteoporosis, osteoarthritis, and fibromyalgia at the hospital.Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.The mean age of the patients was 66.4 years, and 80.5% were female.